Official registry · BMU
Bangladesh Medical UniversityBMU CTR

The Registry Office does not review or approve the safety and science of the studies listed on this website.

Read our full disclaimer for details.

Tuberculosis Treatment Adherence Using Digital Reminders

BDCTR ID
BDCTR-2026-000085
Sponsor
Bangladesh Medical University
Information provided by
Dr Afroza Sultana (Responsible Party)
Last Update Posted
2026-07-28

Completed

No longer looking for participants

Study Overview

Brief Summary

This trial compared digital adherence technology with SMS reminders against standard directly observed therapy on tuberculosis treatment completion.

Detailed Description

Adults starting tuberculosis treatment were randomised to digital adherence technology with SMS reminders or directly observed therapy. Treatment completion was the primary endpoint.

Official Title

Digital Adherence Technology With SMS Reminders Versus Directly Observed Therapy for Tuberculosis Treatment Completion

Conditions

  • Tuberculosis

Intervention/Treatment

  • Behavioral: Digital adherence technology with SMS

Other Study ID Numbers

BMU-MED-2026-005

Study Start

2025-09-01

Primary Completion

2026-05-31

Study Completion

2026-06-30

Enrollment (Estimated)

740

Study Type

Interventional

Resource links provided by the National Library of Medicine

Contacts and Locations

This section provides contact details for people who can answer questions about joining this study, and information on where this study is taking place.

To learn more, please see the Contacts and Locations section in How to Read a Study Record.

This study has 1 location

Bangladesh

  • Rangpur, Rangpur, Bangladesh, 5400

    Completed

    Rangpur Medical College Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

<p>Inclusion Criteria:</p><ul><li>Adults starting first-line tuberculosis treatment.</li><li>Access to a mobile phone.</li></ul><p>Exclusion Criteria:</p><ul><li>Drug-resistant tuberculosis.</li></ul>

Ages Eligible for Study

18 Years and older (Adult, Older Adult)

Sexes Eligible for Study

All

Accepts Healthy Volunteers

No

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Primary Purpose:
Treatment
Allocation:
Randomized
Interventional Model:
Parallel Assignment
Masking:
None (Open Label)

Arms and Interventions

Participant Group/ArmIntervention/Treatment

Experimental: Digital adherence

Behavioral: Digital adherence technology with SMS

Medication sleeves with daily SMS reminders.

Active Comparator: Directly observed therapy

What is the study measuring?

Primary Outcome Measures

Outcome MeasureMeasure DescriptionTime Frame
Treatment completion rateEnd of therapy, up to 6 months

Secondary Outcome Measures

Outcome MeasureMeasure DescriptionTime Frame
Loss to follow-upUp to 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Bangladesh Medical University

Collaborators

National Tuberculosis Control Programme

Study Record Dates

These dates track the progress of study record and summary results submissions to the registry. Study records and reported results are reviewed by the Registry Office to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

First Submitted that Met QC Criteria

2025-08-28

First Posted

2025-08-28

Results Reporting Dates

Results First Posted

2026-07-28

Study Record Updates

Last Update Submitted that Met QC Criteria

2026-07-28

Last Update Posted

2026-07-28

Last Verified

2026-07

More Information

Record History

Terms related to this study

Keywords Provided by Bangladesh Medical University

  • tuberculosis
  • adherence
  • digital health
  • SMS

Plan for Individual Participant Data (IPD)

Plan to Share Individual Participant Data (IPD)?

Not provided

Drug and device information, study documents, and helpful links

Data Monitoring Committee

Yes
Tuberculosis Treatment Adherence Using Digital Reminders (BDCTR-2026-000085) | BMU Clinical Trial Registry